Patent US3934009A successfully refreshed from Google Patents.
US3934009A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Agents for lowering the lipid level in plasma
Assignee: Hoffmann La Roche Inc
•
Filing: 1975-01-09
•
Granted: 1976-01-20
•
Expires: 1995-01-09
Abstract
Abstract N-nicotinoylglucosamine as a lipid level lowering agent in plasma.
Inventors
- 👤 Karl Friedrich Gey
- 👤 Joseph Kiss
- 👤 Hans Lengsfeld
- 👤 Willy Schuep
- 👤 Pierre-Charles Wyss
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-05 04:11
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/7004; A61P; A61P3/00; A61P3/06; C; C07; C07H; C07H13/00; C07H13/02; C07H13/10
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
17 words
A composition useful for lowering the lipid level in plasma comprising N-nicotinoylglucosamine and a pharmaceutical carrier material.
Claim 2
Dependent Claim
17 words
A composition useful for lowering the lipid level in plasma comprising N-nicotinoylglucosamine and a pharmaceutical carrier material.
Claim 3
Dependent Claim
16 words
The composition of claim 1 which contains 200 to 2000 mg. of N-nicotinoylglucosamine per dosage unit.
Claim 4
Dependent Claim
8 words
The composition of claim 1 which contains N-nicotinoyl-D-glucosamine.
Claim 5
Independent Claim
23 words
A method for lowering the lipid level in plasma which method comprises administering to a subject a lipid level lowering amount of N-nicotinoylglucosamine.
Claim 6
Independent Claim
23 words
A method for lowering the lipid level in plasma which method comprises administering to a subject a lipid level lowering amount of N-nicotinoylglucosamine.
Claim 7
Dependent Claim
9 words
The method of claim 4 wherein N-nicotinoyl-D-glucosamine is used.
Claim 8
Dependent Claim
20 words
The method of claim 4 wherein a total of from about 5 to 30 mg/kg of N-nicotinoylglucosamine is administered daily.
Claim 9
Dependent Claim
14 words
The method of claim 4 wherein said N-nicotinoylglucosamine is administered in oral dosage form.
References Cited (Backward Citations)
US3851057A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1979-01-19 | 1979-07-21 | 1980-01-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1983-01-19 | 1983-07-21 | 1984-01-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1987-01-19 | 1987-07-21 | 1988-01-20 | $7700.00 | Window Closed / Lapsed |